Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adolescent Influenza Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01231620
What this trial is testing

Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza

Who this might be right for
Influenza, Human
GlaxoSmithKline 626
Testing effectiveness (Phase 2)Study completedNCT01014988
What this trial is testing

Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital

Who this might be right for
Influenza, Human
GlaxoSmithKline 202
Early research (Phase 1)Study completedNCT06643156
What this trial is testing

Study to Assess the Tolerability, Safety and Efficacy of GP681 Powder for Oral Suspension

Who this might be right for
Influenza
Jiangxi Qingfeng Pharmaceutical Co. Ltd. 44
Not applicableStudy completedNCT03137667
What this trial is testing

School-located Influenza Vaccination Clinics for Adolescents

Who this might be right for
Childhood Influenza VaccinationSchool-located Influenza Vaccination
University of California, Los Angeles 17,650
Large-scale testing (Phase 3)Ended earlyNCT03381196
What this trial is testing

Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Non-Hospitalized Participants With Influenza A Infection Who Are at Risk of Developing Complications

Who this might be right for
Influenza A
Janssen Research & Development, LLC 553
Testing effectiveness (Phase 2)Study completedNCT00900588
What this trial is testing

Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Adolescents

Who this might be right for
Influenza
Sinovac Biotech Co., Ltd
Testing effectiveness (Phase 2)Study completedNCT00192179
What this trial is testing

A Phase II, Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine, CAIV-T in Healthy Children and Adolescents Ages 6 to Less Than 18 Years.

Who this might be right for
Influenza
MedImmune LLC 240
Not applicableStudy completedNCT01705314
What this trial is testing

Trial of Vitamin D to Reduce Respiratory Infection

Who this might be right for
Respiratory Infection
McMaster University 1,300
Not applicableStudy completedNCT02358083
What this trial is testing

Attitudes Toward Human Papillomavirus and Influenza Vaccination Among Mothers of Early Adolescents

Who this might be right for
Human Papillomavirus VaccinesInfluenza VaccinesAttitude to Health
Indiana University 1,165
Not applicableStudy completedNCT01484522
What this trial is testing

Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Children and Youth

Who this might be right for
HIV-1 InfectionH1N1Influenza+1 more
International Maternal Pediatric Adolescent AIDS Clinical Trials Group 149
Testing effectiveness (Phase 2)Study completedNCT00091702
What this trial is testing

Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents

Who this might be right for
HIV InfectionsInfluenza
National Institute of Allergy and Infectious Diseases (NIAID) 300
Large-scale testing (Phase 3)Study completedNCT01227421
What this trial is testing

Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza

Who this might be right for
Influenza
Romark Laboratories L.C. 624
Large-scale testing (Phase 3)UnknownNCT01225770
What this trial is testing

Gargling With Green Tea for Prophylaxis of Influenza Infection in Teenagers

Who this might be right for
Influenza Infection
University of Shizuoka 640
Testing effectiveness (Phase 2)Study completedNCT00943202
What this trial is testing

Sanofi Pasteur, TIV + H1N1, Pediatric Population

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 531
Not applicableStudy completedNCT02165722
What this trial is testing

4 Pillars Toolkit for Adolescent Vaccination

Who this might be right for
Adolescent HPV VaccineAdolescent Influenza Vaccine
University of Pittsburgh 22
Large-scale testing (Phase 3)Study completedNCT01959945
What this trial is testing

Safety, Reactogenicity and Immunogenicity of Flublok Quadrivalent (Recombinant Influenza Vaccine,Seasonal Formulation)

Who this might be right for
Influenza
Protein Sciences Corporation 219
Post-approval studies (Phase 4)Study completedNCT06609811
What this trial is testing

The Interaction Between Mucosal Microbiota Colonization and the Immune Response to an Intranasal Influenza Live Attenuated Vaccine

Who this might be right for
Influenza
Jiangsu Province Centers for Disease Control and Prevention 201
Large-scale testing (Phase 3)Study completedNCT01998477
What this trial is testing

Evaluate the Safety of Two Influenza Vaccines in Children and Adolescents 3 to <18 Years of Age at Risk for Influenza-Related Complications

Who this might be right for
Influenza
Novartis Vaccines 430
Large-scale testing (Phase 3)Looking for participantsNCT06574503
What this trial is testing

Study to Assess the Efficacy and Safety of GP681 Versus Placebo for Postexposure Prophylaxis Against Influenza

Who this might be right for
Influenza
Jiangxi Qingfeng Pharmaceutical Co. Ltd. 748
Testing effectiveness (Phase 2)Study completedNCT00537524
What this trial is testing

Immunogenicity, Safety and Tolerability of Two Doses of a Pre-pandemic Influenza Vaccine in Participants Aged 6 Months to 17 Years

Who this might be right for
Prophylaxis of Avian Influenza
Novartis Vaccines 471
Next Page